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In this paper, we describe the use of epidemiological methods to understand and reduce honey bee morbidity and mortality. Essential terms 
are presented and defined and we also give examples for their use. Defining such terms as disease, population, sensitivity, and specificity, 
provides a framework for epidemiological comparisons. The term population, in particular, is quite complex for an organism like the honey bee 
because one can view “epidemiological unit” as individual bees, colonies, apiaries, or operations. The population of interest must, therefore, 
be clearly defined. Equations and explanations of how to calculate measures of disease rates in a population are provided. There are two 
types of study design; observational and experimental. The advantages and limitations of both are discussed. Approaches to calculate and 
interpret results are detailed. Methods for calculating epidemiological measures such as detection of rare events, associating exposure and 
disease (Odds Ratio and Relative Risk), and comparing prevalence and incidence are discussed. Naturally, for beekeepers, the adoption of any 
management system must have economic advantage. We present a means to determine the cost and benefit of the treatment in order 
determine its net benefit. Lastly, this paper presents a discussion of the use of Hill’s criteria for inferring causal relationships. This framework 
for judging cause-effect relationships supports a repeatable and quantitative evaluation process at the population or landscape level. Hill’s 
criteria disaggregate the different kinds of evidence, allowing the scientist to consider each type of evidence individually and objectively, using 
a quantitative scoring method for drawing conclusions. It is hoped that the epidemiological approach will be more broadly used to study and 
negate honey bee disease. 
 
Métodos estándar epidemiológicos para entender y mejorar la 
salud de Apis mellifera 
Resumen  
En este trabajo se detalla el uso de métodos epidemiológicos para entender y reducir la morbilidad y la mortalidad de las abejas. Se presentan 
y definen algunos términos esenciales y también se ponen ejemplos de su uso. La definición de términos tales como enfermedad, población, 
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sensibilidad y especificidad, proporciona un marco de referencia para las comparaciones epidemiológicas. El término población, en particular, 
es muy complejo en un organismo como la abeja de la miel, porque uno puede ver la "unidad epidemiológica" como las abejas individuales, 
las colonias, los colmenares o incluso, determinadas operaciones. La población de interés debe, por lo tanto, estar claramente definida. Se 








Key words: COLOSS, BEEBOOK, honey bee Apis mellifera, epidemiology, disease, case definition confidence interval, odds ratio, relative risk, 
Hills Criteria 
1. Basic epidemiological terms and 
calculations 
Epidemiology is traditionally defined as the study of the distribution 
and determinants of disease within a human population (Woodward, 
2005). To accomplish this, epidemiological studies attempt to identify 
factors which may explain or contribute to disease outbreak. Once 
identified, these factors not only inform future clinical etiological 
studies, but also, and perhaps more importantly, they inform disease 
prevention and control programmes (Mausner and Kramer, 1985). 
The success of epidemiologists in reducing the occurrence of human 
disease over the last century is undeniable. The identification of 
factors that contribute to the occurrence of diseases such as lung 
cancer (smoking), sexually transmitted diseases (unprotected sex), 
and cardiovascular disease (high blood pressure) have permitted 
targeted community health initiatives aimed at preventing or 
controlling risk factor exposure. These initiatives, in turn, have helped 
reduce the rate of disease in targeted populations (Mausner and 
Kramer, 1985; Koepsell and Weiss, 2003; Woodward, 2005).  
Considering the success of human epidemiology, it is not 
surprising that epidemiological methods have been adopted by those 
wishing to understand and reduce disease outbreak in non-human 
animals (epizootiology) (Nutter, 1999). The term epidemiology is now 
widely adopted by those studying disease and disease determinants in 
non-human organisms, including honey bees, and will be the term 
used in this paper. Nutter (1999) argued that the application of 
epidemiological methods for understanding disease occurrence in 
plant, human, and animal populations involves the implementation of 
six common steps which include defining disease in quantitative terms 
and quantifying state and rate variables of the disease system. An 
alternative way to look at this process is to consider the "virtuous 
epidemiological cycle" (Fig. 1) which outlines the various steps 
involved in quantifying disease in a population, determining risk 
factors contributing to disease occurrence, determining methods to 
reduce disease occurrence and then evaluating the effectiveness of 
these methods (Toma et al., 1991). 
A comprehensive review of all of these steps is well beyond the 
scope of this paper. Similarly, much of the data used by 
epidemiologists are derived from surveillance efforts, a discussion of 
which is also beyond the scope of this paper, but has received 
attention in other recent work (Hendrikx et al., 2009, vanEngelsdorp 
et al., 2013). Instead, we focus on presenting and defining the 
vocabulary needed to implement epidemiological studies, and then 
outline study design, analysis and interpretation. It is also the intent 
of this paper to present a framework for understanding and initiating 
ongoing and future studies of honey bee health. Unless otherwise 
noted, the following terms and concepts have been adapted from 
Koepsell and Weiss (2003).  
Fig. 1. The virtuous circle of epidemiology: Step 1. describe health 
characteristics of the population in space and time (descriptive 
epidemiology); Step 2.  analyse data and mechanisms of development 
of the disease to understand behaviour (analytical epidemiology); 
Step 3. produce, select and apply control or preventive measures 
(operational epidemiology); Step 4. give necessary information that 
permits the follow up of measures (evaluative epidemiology); In 
addition,  changing epidemiological methods should be supported by 
theoretical epidemiology (modelling). 
1.1. Disease 
To successfully develop tools which either quantify the rate of disease 
development in a population or quantify the factors which may 
contribute to disease occurrence, the “disease” of interest must be 
clearly defined. Broadly speaking, disease is any departure from 
perfect health. When applied to specific studies, a precise definition - 
the case definition - must be developed which unambiguously allows 
subjects to be classified as a case or not.  
 
1.1.1. Case definition 
The case definition is the operating definition of a disease for study 
purposes. Aristotle identified two crucial components that made for a 
good case definition: 1. it specifies characteristics common to all 
diseased individuals; and 2. it specifies how diseased individuals differ 
from non-diseased individuals (Koepsell and Weiss, 2003). Ideally, the 
characteristics used to identify the disease should be simple and 
recognizable by independent observers in different geographies. 
Because characteristics cannot always be recognized in the field, case 
confirmation by laboratory analyses is sometimes necessary. Case 
definitions, especially for emerging or newly identified diseases, often 
suffer from having limited specificity. Further, case definitions for a 
disease can evolve as understanding of a disease changes and / or 
the diagnostic tests performed to determine a diagnosis are refined.  
An outline of different classifications of case definitions has been 
provided by the World Health Organization (WHO, 1999). When 
applied to apiculture, it is important to define the “epidemiological 
unit” for which the case definition is being applied (discussed in 
greater detail in section 1.2). Epidemiological units are the groups 
which make up the population of interest, and can range from 
individual bees, colonies, apiaries, and operations.   
 
1.1.2. Test sensitivity and specificity 
Many case definitions are based on laboratory or clinical tests, but 
tests in themselves are prone to errors either by misidentifying truly 
positive cases incorrectly as negative cases, or truly negative cases as 
positive cases. The accuracy of a test is primarily given as sensitivity 
and specificity.  
  
Sensitivity 
Sensitivity is the probability that a human or animal will have a 
positive test result if indeed the human or animal does have a 
disease.  This is expressed as: P(T+|D+),  where P is the probability, 
T+ is a  positive test result and D+ is a disease being present.  In 
applied epidemiology, sensitivity is often expressed as a proportion, 
and thus expressed as equation 1.1.2.a. 
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Specificity 
Similarly, specificity is the probability that a human/animal will have a 
negative test result if indeed it is disease free. This is expressed as: P
(T-|D-),  where P is the probability, T- is a negative test result and D- 
is the disease not being present. In applied epidemiology, specificity is 
often expressed as the proportion of non-diseased (healthy) animals 
that test negative, expressed as equation 1.1.2.b. 
 
1.1.2.1. Calculating confidence intervals for a proportion 
Sensitivity and specificity  are based upon a sample of test results 
around which there is uncertainty.  In epidemiology, uncertainty can 
be expressed as confidence interval (CI). Typically, they are 
expressed as a 95% confidence interval (95% CI). Briefly, confidence 
intervals indicate the precision of the estimate where a wide 
confidence interval indicates that the estimate is not very precise.  In 
statistical terms, if we were to repeat the test 100 times, the point 
estimate of 95 of those 100 tests would lie within the confidence 
interval. Implicit in presenting 95% CI is the assumption that the 
sample from which the CI is derived is representative of the 
population from which the sample was drawn.  Representativeness is 
best achieved when the sample is randomly drawn from the 
population of interest. As long as the sample size is greater than 30, 
the 95% CI can be calculated using equation 1.1.2.c. 
 
 
Where Zα is the (1-α/2) percentile of the standard normal distribution 





In cases where the sample size is smaller than 30, where np < 5, 
n(1-p) < 5  or the proportion estimate is close to 0 or 1.0, standard 
statistical software tools (e.g. SAS JMP) will use the binomial 
distribution to calculate the CI.  Estimates can also be determined by 
replacing Zα in equation 1.1.2.c above with the critical value from a 
published binomial statistical table.  
 
1.1.3. Positive and negative predictive values 
While sensitivity and specificity primarily measure a test’s accuracy, 
epidemiologists use two other measures, positive and negative 
predictive values, to help describe the certainty of a specific test 
result. A Positive Predictive Value (PPV) is the probability that a 
person/animal with a positive test result truly has a disease P(D+/T+). 
PPV is typically expressed as a proportion (Equation 1.1.3.a). 
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A Negative Predictive Value (NPV) is the probability that a person/
animal with a negative test result truly does not have disease  
P (D-/T-). NPV is typically expressed as a proportion (Equation 1.1.3.b). 
PPV and NPV decrease and increase, respectively, as a function of 
the prevalence of the disease in a population. As the prevalence of a 
disease increases so does the PPV while the NPV decreases (Box 1). 
 
1.2. Population 
Defining the population under study is a critical component of all 
epidemiological studies. Like case definitions, the population under 
study must have characteristics which set its members apart from non
-members. These members can then be categorized into smaller 
groups for the purposes of comparing disease levels between different 
sub-groups within the study population. Defining the population of 
interest in apiculture represents a unique challenge as there is a 
hierarchy of population units, each of which could be considered 
“individual members” (Table 1). In apicultural terms there are several 
levels of potential interest, thus there are several different definitions 
for what makes up the individual of interest. 
 
 Individual bees within a colony 
 A group of colonies located within one area make up an 
apiary 
 One or more groups of apiaries owned or managed by one 
beekeeper make up an operation 
 Apiaries contained within a defined geography make up a 
region 
 
Characteristics that commonly define sub-groups within any of 
these given populations often differ according to hierarchal 
classification of the population, but broadly include individual 
attributes, such as: age (i.e. bee cohort at the colony level (Giray et al., 
2000); genetics (i.e. patriline at the colony level (Estoup et al., 1994), 
queen type at the apiary level); size of operations; production 
objectives; and management style (at the regional level) (Table 1). 
Once the defining criteria for a population have been established, the 
membership (epidemiological unit) of that population can be 
quantified. However, size may change over time because new 
members are added or existing members are removed. 
 
1.3. Measures of disease in a population 
Comparing frequency of disease between sub-groups of a population 
underpins most epidemiological research (see study design in Section 
2.0). As such, various ways to quantify disease frequency have been 
developed.  
 Box 1. 
Over the inspection season of 2004 and 2005, Pennsylvania state bee 
inspectors preformed 107 Holst’s milk tests on suspect cases of clinical 
American foulbrood disease (for more information about this test, see 
the BEEBOOK paper on American foulbrood (de Graaf et al., 2013)). 
Ninety samples tested positive with the Holst’s milk test (Holst, 
1945), of which 89 were confirmed in the laboratory to be AFB infection. 
Confirmation of diagnosis was performed by culturing a smear of 
diseased larvae sampled from the same colony. The Holst’s milk test 
resulted in 14 negative and three inconclusive results. The later were 
discarded. Six of the negative samples were later diagnosed to have 
had AFB when companion samples were cultured (vanEngelsdorp, 
unpublished data). The sensitivity and specificity as well as the positive 





    
Condition (as determined  
by AFB Culture)   




Test Positive 89 1 90 
Test Negative 6 8 14 
  Total 95 9 104 
Therefore:      
Because the denominator is less than 30, the normal approximation 
of the binomial distribution cannot be assumed and for the calculation 






Thus, when a Holst’s milk test is performed and comes back positive 
we are 99% certain the sample does contain American Foulbrood 
spores, while if the Holst’s milk test comes back negative we are 
53% sure that the sample does not have American foulbrood spores. 
1.3.1. Point prevalence  
Point prevalence is the frequency of ongoing disease in a defined 
population at a certain point in time (Equation 1.3.1). 
 
 
The method for calculating the 95% confidence interval for point 
prevalence is outlined in section 1.1.2.1. Again, it is important to 
stress that calculating the CI assumes the sample pool is 
representative of the population as a whole, this is best achieved if 
the sample was randomly drawn from the population. The estimate of 
the point prevalence is affected by the likelihood that a disease will be 
detected during a given inspection. Diseases which occur for only 
short periods of time are less likely to be observed during an 
inspection than are diseases that are more chronic (Box 2). 
 
1.3.1.1. True versus apparent prevalence. 
As can be inferred from the discussion above, the reported point 
prevalence of disease is influenced by the case definition and the test 
employed to determine a case’s outcome. It is conceivable that for 
some diseases, in-field examination for phenotypic expression of 
disease may be negative while laboratory tests determine disease 
presence (i.e. deformed wing virus). In such cases, two types of 
prevalence can be specified; true prevalence with all cases of disease 
existing at a specific point in time, and apparent prevalence that is 
determined by test results (i.e. in-field examination, molecular test, 
etc.). The apparent prevalence is subject to the accuracy of the test 
(sensitivity and specificity). 
 
1.3.2. Incidence rate 
Incidence is the occurrence of a new case if a disease and is best 
calculated if the exact period of time at risk for each participant is 
known. The incidence rate is the proportion of incident cases in a 
population at risk of becoming an incident case during a specified 





The incidence rate (IR) accounts for the fact that the number of 
incident cases is dependent on the size of the population observed 
and the time period over which individuals were observed. Because 
IRs are measured over time, the population under observation may 
change. Where precise data on the population at risk of becoming an 
incident case over the period is not available, the average population 
of individuals at risk for the time period is commonly used as the 
denominator. This technique is particularly useful when attempting to 
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Table 1. Hierarchy of possible populations of interest, types of members, and common groupings or sub-categories for comparing members 
within the same population in honey bee epidemiological studies. 
Population Members 
Common groupings / 
subcategories for comparisons 
Colony Bees 
Caste (worker vs drone) 














In the summer of 2006 apiary inspectors in Pennsylvania inspected a 
sub-set of beekeeping operations in the state. In total, 1,706 apiaries 
were inspected containing 11,285 colonies. Clinical signs of Chalkbrood 
(CB) disease were found in a total of 384 colonies located in 156 
apiaries (vanEngelsdorp, unpublished data). 
  
 




                           = 0.09 ± 0.017 
                         = (0.073 – 0.107) = 7.3-10.7% 
  
 




                           = 0.034 ± 0.0033 
                         = (0.0307 – 0.0373) = 3.1 -3.7% 
Thus, assuming that the inspected apiaries were representative of 
the entire Pennsylvanian population, Chalkbrood was present in 9% 
of all colonies (95% CI: 7.3-10.3%) while 3.4% (95% CI 3.1 – 3.7%)  
of all colonies had clinical signs of the disease. 
  
calculate the incidence rate of a condition which is very likely to be 
self-reported in a large population. IRs are presented as a number  
per time, or per unit-time if the exact time at risk is known for each 
member of the population.  
 
1.3.2.1. Calculating confidence intervals for incidence rates 
The confidence interval for an IR can be calculated for a population 
with the same time at risk using equation 1.1.2.b, where Z∝ is based 
on the Poison distribution and n is an individual-time constant. In 
reality the IR is often not homogenous within a population. For 
instance, a random sample of honey bee colonies would express 
hygienic behaviour differently. As highly hygienic colonies are more 
likely to resist brood diseases, these colonies would be less likely to 
be diagnosed with the condition. Conversely, it is conceivable that the 
diagnosis of a certain brood disease in a given colony is a marker for 
increased susceptibility for the disease. Therefore, in comparison to 
disease-free colonies, a second diagnosis is more likely to occur in 
colonies that were previously diseased. This phenomenon is referred 
to as extra-Poison variation and if left uncorrected will result in a 
confidence interval that is too narrow. To address this, a multivariate 
logistic regression model with terms for previous disease should be 
employed.   
Just as the IR is not the same for all individuals in a population, it 
is also not likely to be constant over time. The prevalence of many 
bee diseases changes over time, thus affecting 95% CI calculation. 
This problem can be overcome by restricting analysis to sub-periods 
or “time bands” so that differences in IR over time are not a factor. 
Alternatively, time itself can be used as a predictor of disease when 
performing a multivariate analysis (Koepsell and Weiss, 2003). 
 
1.3.3. Special cases of incidence 
Over the last few years considerable effort has been placed on 
documenting winter losses in different regions of the world. As a 
result, different methods to calculate and report winter losses have 
been developed including Total Loss, Average Loss (vanEngelsdorp  
et al., 2011).    
 
1.3.3.1. Total colony loss (TL) (the cumulative incidence of 
mortality) 
This is the percentage of colonies lost in a specific group over a fixed 
period of time. This figure is the most accurate snap shot of loss in a 
defined group, such as in an operation or geographic region. If all 
colonies in a region were enumerated it would give a precise figure 
for the proportion of all colonies that died in that region. However, 
within the population of interest, operations with large numbers of 
colonies will have a greater influence on the total colony loss metric 
than will the operations with only few colonies. Total Colony Loss in 
an operation or in a defined group is calculated by dividing the total 
number of colonies that died over a given time period (Tdead) by the 
total number of colonies at risk of dying in a given time period  
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Where the total number of colonies at risk of dying (TColonies at risk of 
dying) over a period was calculated by adding the number of colonies at 
the start of the period (TStart) with the number of splits made by the 
beekeepers over the period (TSplits) and the number of colonies 
purchased over the period (TPurchased) and then subtracting the number 
of colonies removed (sold or given away) over the period (TRemoved). 
And where the total number of colonies that died (TDead) was 
calculated by subtracting the total number of colonies at the end of a 
period (TEnd) from the total number of colonies at risk of dying for the 
period (Tcolonies at risk of dying). 
Where period was the defined period of time for which colony loss 
was analysed. The unit of time,  is the period defined by the time 
between TStart and TEnd. This unit is often not reported and is often 
loosely defined by the season encompassed by that time period (e.g. 
winter). 
And where, respondents in a specific group are the group of 
respondents for whom valid loss data was collected. 
 
1.3.3.1.1. 95% CI for total loss 
Because total loss is a proportion, theoretically its confidence interval 
can be calculated using equation 1.1.2.c. This approach is valid when 
calculating a 95% CI for losses within one operation. However, if all 
the colonies in an operation are measured, one’s sample is the whole 
population, there is no need to calculate the  CI. When total losses 
are calculated for a region,  the losses of several operations are being 
combined, using the previously mentioned equation to calculate the 
95% CI is inappropriate as the basic assumption that the total number 
of dead (TDead) is independent of the total colonies at risk (TColonies 
at risk of dying) is not met. In such cases the quasi-binomial family is 
introduced to take into account the increased standard error 
introduced by dependence within the data (vanEngelsdorp et al., 
2011). An R script example which allows for such calculations is given 
in Box 3.  
 
1.3.3.2. Average loss (AL) 
Average loss is the mean % of the total colony loss experienced by 
respondents in a defined group over a defined period of time. This 
metric is most appropriately used to compare groups partitioned by 
different risk factor exposures (see study design  in Section 2.1.1.3). 
Usually average loss calculations are heavily influenced by smaller 
beekeeper operations as they often compose a larger portion of the 
response population. Average Loss is calculated by dividing the 
summed total colony loss of respondents (TLi) within a specified 
group by the number of respondents in that group (N) and then 




1.3.3.2.1. 95% CI for average loss 
Like other proportions, average loss confidence intervals can be 
calculated using equation 1.1.2.c. As mentioned previously, average 
losses are often skewed by smaller operations resulting in a Poisson 
distribution of losses rather than a normal distribution. When the 
number of respondents exceeds 100, the Poisson distribution 
resembles a normal distribution so adjustment in the equation 1.1.2.c 
is not needed.  However, when the number of respondents is less 
than 100, the rate multiplier for the 95% CI can be determined by 
looking up the lower and higher rate multiplier in an appropriate table  
(e.g. Paoli et al., 2002) (Box 3.). 
 
2. Study design 
Epidemiologists endeavour to reduce disease occurrence in a 
population. To achieve this one must quantify disease at the 
population level and determine risk factors that contribute to disease 
occurrence. Two study designs can be used to determine the 
association of exposure with a health outcome: observational and 
experimental. In an experimental design, the exposure is determined 
by the investigator, whereas in an observational design, the exposure 
is not determined by the investigator or the study (i.e. exposure is 
under the control of the study participants or the participant’s 
environment). For example, if an investigator determines which hives 
are treated for Nosema and which are not, then the study design 
would be considered an experimental design. In an observational 
study, the investigator would observe the Nosema responses for 
beekeepers who applied and who did not apply treatment for 
Nosema, wherein this case, the application of the treatment is 
determined by the beekeeper. 
 
2.1. Observational study designs 
2.1.1. Cross-sectional studies 
Cross-sectional studies are a point-in-time study, such as a one-time 
disease surveillance survey, and are typically used to estimate disease 
prevalence or the simultaneous association between a risk factor and 
a disease. In this design, the exposure and outcome for each subject 
in the study are ascertained simultaneously. This simultaneity often 
leads to difficulty in conclusively establishing the temporal relationship 
between the exposure and the outcome. It is also important to note 
that chronic conditions are more likely to be identified in a survey 
because they are more likely to persist in a population and are more 
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 Box 3.  
In the dialogue below, text starting with # describes the R script 
which follows.  Text in bold is R script and text in italics is output. 
 # import data (format csv) 
data <- read.csv("C:\\Users\\ ruchersWinterLoss.csv", 
header = T, sep = ",") 
summary(data) 
Colony              nCol              nDead              nAlive 
Min. : 1.00        Min. : 1.00      Min. : 0.00    Min. : 0.00 
1st Qu.: 44.75  1st Qu.: 2.75   1st Qu.: 1.00    1st Qu.: 0.00 
Median : 88.50  Median: 5.00    Median : 3.00    Median : 2.00 
Mean : 88.50   Mean : 96.51    Mean : 33.60    Mean : 62.91 
3rd Qu.: 132.25  3rd Qu.: 12.00   3r Qu.: 8.25   3rd Qu.:  5.00 
Max.: 176.00    Max.: 6000.00   Max.: 2000.00   Max.: 5000.00 
attach(data) 
# general linear model, family quasibinomial 
wloss.glm1 <- glm(cbind(nDead, nAlive)~1, fami-
ly=quasibinomial, data=data) 
# generate confidence intervals via GLM 
require(boot) 
Loading required package: boot 
prop <- with(data, sum(nDead)/sum(nCol)) 
# Verification : 'raw' confidence intervals (Wald formula) 
nColonies <- sum(data$nCol) 
#deriving the 95% confidence interval 
prop+c(-1,1)*1.96* sqrt(vcov(wloss.glm1))) 
[1]  0.194553621   0.501666796 
#call specific output and bind them together as a single object 





[,1]      [,2]                 [,3]           [,4] 
titles  "tot loss"           "SE"             " Conf. Int."        "" 
stats  "0.348110208406923" "0.0794099959221504" "0. "     
"0.194553621   0.501666796" 
 
Thus, this table states the total loss was 34.8% with a standard error 
of 7.9 percentage points, giving a 95% CI of 19.3% to 50.2%. 
common. Therefore this study design is less useful for studies of rare 
exposures and rare outcomes. However, cross-sectional studies can 
be inexpensive, relatively quick to conduct, and are used to identify 
potential associations between exposures and outcomes that warrant 
further research with more rigorous population-based study designs. 
An example of a cross-sectional study is when a bee inspector 
examines hives in an apiary for characteristics, such as size, strength, 
activity, and disease and then uses these data to generate estimates 
of the prevalence of hives with a particular disease (e.g., Chalkbrood) 
in a region. 
 
2.1.1.1 Detection of rare events 
Epidemiological surveys are often designed to detect (or not detect) 
relatively rare events in a population. It is often impractical or 
impossible to prove that a disease or pest organism is not found in a 
region with 100% certainty. However, a properly designed disease 
surveillance system can give a set level of confidence that a disease 
or pest species is not present in a defined population at a predefined 
prevalence level. These results, by extension, can help to declare a 
region as free from a particular disease or parasite which may have 
important implications for policy makers.  
In most cases, disease prevalence in individual members (i.e. 
colonies) will be categorical, that is the disease will either be present 
or absent (Fosgate, 2009). The number of individuals that would need 
to be examined (n) in an infinite population (where the number of 
individuals exceeds 1,000 members) given a minimum disease 
prevalence (P) is given by equation 2.1.1.1.a (Hill, 1965). 




Where α is the confidence with which one wants to be certain the 
disease is detected. In finite populations (< 1,000) with a population 
size of N, the number of individuals that need to be examined (n) to 
be certain to detect at least one positive case at a defined confidence 
(α), where the minimum  prevalence of disease in the population (P) 





Where D = N × P. Both of these approaches assume tests which 
are 100% sensitive, which is often unrealistic. In cases where 
sensitivity is imperfect but known (S), the number of individuals that 
would need to be examined (n) in an infinite population to be 
confident (α) of detecting at least one diseased case with a disease 
prevalence of  P is given by equation 2.1.1.1.c 
Equation 2.1.1.1.c 
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Box 4. 
The bump technique is a new method meant to detect the presence 
of Tropilaelaps  mites (Anderson et al., 2013).  This test, when  
applied to colonies that have an average infestation of 4.6 ± 0.06 
mites per 100 brood cells, has a sensitivity of 36% (Pettis, Rose, and 
vanEngelsdorp, unpublished data). How many colonies need to be 
tested in a region with more than 1,000 colonies in order to detect 
one infected colony with 95% Confidence, assuming that 5% of  
colonies are infested? 
 
     
Thus, 165 randomly selected colonies would need to be tested to be 
95% confident of detecting at least one positive colony given a 5% 
infestation rate. 
 
2.1.1.2 Data analysis and interpretation: making associations 
between exposure and disease in cross-sectional studies 
When cross-sectional studies collect information on disease 
prevalence and simultaneous exposure to factors that may contribute 
to disease, Odds Ratios (ORs) can be used to calculate the degree of 
association between concurrent exposure and disease state. We can 
calculate the odds of exposure among cases compared to the odds of 
exposure among non-cases (controls). The OR is the odds of 
exposure in an individual who was diseased divided by the odds of 





Where a,b,c,d are defined by the Table 2. The Confidence 





2.1.1.3. Significance of odds ratio measures 
Generally speaking OR (and Relative Risk see below) values greater 
than 1 indicates that a disease is more likely to occur in an exposed 
group as compared to an unexposed group. Conversely, an OR value  
less than 1 means that a disease event is less likely to occur in an 
exposed groups compared to unexposed group. An OR that has a 95% 
CI that overlaps with 1 is indicative of an OR that is not a significant 
(Box 5). 
  Disease   
Exposure Present Absent All Individuals 
Yes a b a+b 
No c d c+d 
Table 2. Structure of data for calculation of odds ratio. 
2.1.1.3 Comparing prevalence / incidence rates 
Some cross sectional studies may collect information on presumptive 
risk factors as well as health outcomes.  For instance, winter loss 
surveys may collect information on management practices utilized in 
addition to health outcome (mortality). When the study permits the 
population to be divided based on different “exposures”, the measures 
of disease outcomes (prevalence or incidence rates) can be 
compared. When prevalence is the measure of comparison, 
differences in exposure between two groups separated by risk factor 
exposure can be compared using a Chi-Square test, or in cases where 
fewer than 5 cases were observed in a given cell, the Fisher’s exact 
test.  Resulting from this approach is a p value, which simply provides 
a goal post by which we can assert that the populations differ 
significantly (typically when a p ≤ 0.05 is calculated, the prevalence 
rates in two populations are considered to be significantly different).  
However, this approach does not give any indication as to the size of 
the effect of exposure to the risk factor. The magnitude of this effect 
can be gleaned by comparing the 95% CI of the point prevalence 
estimates. Generally speaking, populations that have point estimates 
with overlapping 95% CI are not significantly different, while those 
who do not have overlapping populations are.  More importantly, the 
95% CI aid in the interpretation of any exposure effect in that it puts 
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Box 5. 
Between 1996 and 2007 the apiary inspection programme in the Commonwealth of Pennsylvania inspected 19,933 apiaries for clinical signs 
of chalkbrood and sacbrood disease. Over all inspections, 1,831 apiaries were found to have at least one colony with chalkbrood, and 547 
colonies were found to have sacbrood.  212 apiaries had colonies infected with chalkbrood and sacbrood at the same time (vanEngelsdorp, 





Thus, apiaries infected with chalkbrood are 6.9 times more likely to be infected with sacbrood when compared to apiaries not infected with 
chalkbrood. 
  
The 95 % confidence interval for the Odds Ratio =  
 
Where s.e. =  
 
Thus, the 95% confidence interval in this example is = 5.8 -8.3. The confidence interval does not include 1.0, therefore the relationship 
between Sacbrood and Chalkbrood is statistically significant, and is unlikely due to chance. 
    sacbrood   
  apiaries positive negative total 
chalkbrood positive 212 1,619 1,831 
negative 335 17,767 18,102 
  total 547 19,386 19,933 
the upper and lower bounds on possible magnitude of any effect 
(Gardner and Altman, 1986).  
 When cross sectional studies result in incidence rates (e.g. 
from winter loss surveys), rates between groups separated by 
exposure can be compared using ANOVA and other basic parametric 
tests. As is the case for the non-parametric tests mentioned in the 
above paragraph, these will result in a P value which indicates if the 
incidence rates in the populations differ. This result is of limited value 
because not only is it of interest that the populations are different; 
the magnitude of the difference is of note. Calculating and comparing 
95% CI for the point estimate of Incidence rates has more meaning 
than stating that the two groups within a population are different or 
not based on a statistical test (Box 6). 
 
2.1.1.4 Multiple regression models 
While comparing exposure prevalence in sub-groups of a population 
may have benefits in elucidating exposures that have pronounced 
effects on disease, often, several factors may contribute to disease 
outcomes.  In these cases, multivariate regression analysis can be 
conducted to highlight exposure factors that differ between groups.  
If the outcome is at the individual level, a multivariate logit or probit 
may be appropriate.  If the outcome is at a group level, a multivariate 
logistic regression may be preferred, although if most ratios or 
percentages range between 0.3 and 0.7, a linear regression can often 
give a good fit.  Standard statistical packages (SAS, R, etc.) permit 
fairly straightforward disease modelling for datasets that are 
complete, that is have all the needed exposure measures present for 
each "diseased" and "non-diseased" epidemiological unit. However, 
frequently, cross sectional studies have incomplete data.  
 
2.1.1.5. Classification and regression tree (CART) analysis 
This analysis is useful for modelling diseases that have multiple 
contributing factors and an incomplete data set for quantifying 
possible risk factors in both the disease and disease-free populations. 
The CART analysis is a non-linear and non-parametric model, fitted by 
binary recursive partitioning of multidimensional co-variate space 
(Breiman et al., 1984, Saegerman et al., 2004, Speybroeck et al., 2004). 
Using CART 6.0 software (Salford Systems; San Diego, USA), the 
analysis successively splits the data set into increasingly 
homogeneous subsets until it is stratified and meets specified criteria. 
The Gini index is normally used as the splitting method, and a ten-fold 
cross-validation is used to test the predictive capacity of the trees 
obtained. The CART analysis performs cross-validation by growing 
maximal trees on subsets of data, then calculating error rates based 
on unused portions of the data set. 
The consequence of this complex process is a set of fairly reliable 
estimates of the independent predictive accuracy of the tree, even 
when some data for independent variables are incomplete and/or 
comparatively scarce. Further details about CART are presented in 
previously published articles (Saegerman et al., 2011). 
 
2.1.2 Cohort studies 
Cohort studies allow an investigator to estimate the disease incidence 
rate because the study measures the time that participants don’t have 
the disease. As compared to cross-sectional studies, cohort studies 
are better able to assess causality because the temporal relationship 
of exposure preceding outcome is not subject to question. This design 
is implemented through three steps. First, exposed and unexposed 
individuals who are free of the outcome of interest are identified and 
become the cohort. Next, each cohort is observed for a minimum 
period of time to determine if the outcome of interest develops. The 
risk of developing the outcome is calculated separately for the 
exposed group and for the unexposed group. Finally, the risk for the 
exposed and unexposed study subjects is compared, often by 
estimating the relative risk. Essentially, the incidence of disease over 
time is measured in exposed and unexposed individuals to determine 
the risk of disease in relation to exposure to a factor of interest. These 
studies can be performed retrospectively, where a post-hoc study is 
executed on previously collected data, or prospectively, where study 
subjects who do not have the outcome of interest are followed 
forward through time. Examples of cohort studies in honey bees  
10 vanEnglesdorp et al. 
Box 6. 
A winter loss survey was conducted to determine the winter mortality 
(Oct 1 – April 1) of US beekeepers over the winter of 2010-2011 
(vanEngelsdorp et al., 2012).  A subset of these respondents also 
answered various questions regarding their management practices. 
In all 1,074 beekeepers indicated they had used a known varroa mite 
control product in a majority of their hives over the previous year, 
while 1,675 responding beekeepers reported not using any known 
varroa mite control product in any of their hives. Beekeepers who 
used a known varroa mite control product lost 29.5% (95% CI 27.5 - 
31.4%) of their colonies, while those who did not indicate they used 
a known varroa mite control product lost 36.7% (95% CI 34.9 - 38.55) 




As the two confidence intervals do not overlap we know the two 
populations are different, we can say that beekeepers who treated 
with a known varroa control product lost 7 fewer overwintering 
colonies per 100 than those who did not; in other words beekeepers 
who treated with a known varroa control product lost 20 % 
(7/37*100 %) fewer colonies than those who did not. 
 
 
include Genersch et al. (2010), Gisder et al. (2010) and 
vanEngelsdorp et al. (2013). 
 
2.1.2.1 Data analysis and interpretation: making associations 
between exposure and disease in cohort studies 
If the investigator knows the exact time that each participant was at 
risk, it is possible to calculate the incidence rate. Incidence rates can 
be compared between different groups within a population in the 
same way as prevalence rates can, that is using standard statistical 
tests, and/or, (perhaps more appropriately) comparing 95% CI 
between two groups in a population. Another valuable tool that can 
be used to highlight possible associations between disease outcome 
and risk factor exposure is the calculation of relative risk. 
2.1.2.2. Relative risk  
The Relative risk is a  measure of the chance of developing a disease 
after a particular exposure. It is calculated by dividing the incidence 
rate in an exposed population (Ie) by the incidence rate in an 
unexposed population (Io). (Equation 2.1.2.2.)  




Where a, b, c, d are determined by Table 3. 
 
2.1.2.3. The confidence intervals for relative risk  
The Confidence Intervals for Relative Risk can be calculated using the 
equation given in Equation 2.1.2.3. 
 Equation 2.1.2.3. 
There are numerous online RR calculators (e.g. http://
faculty.vassar.edu/lowry/VassarStats.html). Common statistical 
packages often give RR and associated CI when performing tests on 
2x2 contingency tables. Caution should be used, however, to ensure 
that the data entered in such packages are in keeping with the layout 
presented in Table 3. 
 
2.1.2.4. Significance of relative risk measures 
Generally speaking RR (and Odds Ratio) values greater than 1 
indicates that a disease is more likely to occur in an exposed group as 
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compared to an unexposed group. Conversely, a RR value less than 1 
means that a disease event is less likely to occur in an exposed group 
compared to unexposed group. The confidence that a RR value is a 
measure of a real increased measurable risk, and not a consequence 
of chance, is dependent on several factors: 1. the size of the 
population; 2. the variability in the responding population; and 3. the 
intensity of the effect.  All of these attributes are accounted for in the 
calculation of the 95% CI. Thus, to gauge if a RR measure truly does 
indicate an increase or decrease in risk of disease after exposure, one 
should examine a RR 95% CI. If the interval overlaps with 1, the RR 
cannot be considered significant (Box 7).   
 
2.1.3. Case-control studies 
In contrast to cohort studies where participants are identified by 
exposure status, participants in case-control studies are identified by 
their disease or outcome status. Cases are participants who have 
developed the outcome of interest. Controls are subjects who do not 
have the outcome of interest and provide an estimate of the 
frequency of exposure in the population at risk. In this retrospective 
study design, cases and controls are first identified. Subsequently, the 
Box 7. 
A longitudinal study was set up to monitor colonies for mortality and other factors as they moved up and down the east coast to pollinate 
crops.  Forty nine colonies were examined in June of 2007, and 20 of them were found to have entombed pollen during the examination.   
In January 2008,  15 of the colonies that had entombed pollen were dead, as compared to the 6 colonies that died in the cohort without 





95% CI = 1.18-7.61 
 
As the RR is greater than 1 and the 95% CI do not overlap with 1, we can say that the increased risk of mortality associated with entombed 
pollen is significant.  For every colony that died by January that did not have entombed pollen in June, 3.6 colonies died that did have  
entombed pollen. 
 
    Outcome (January 2008)   
  Colonies Dead Alive Total 
Entombed pollen (June 
2007) 
Positive 15 5 20 
Negative 6 23 29 
  Total 21 28 49 
  Outcome   
Exposure Present Absent All Individuals 
Yes A b a+b 
No c d c+d 
Table 3. Structure of data for calculation of Relative Risk. Both disease 
outcome and risk factor exposure are dichotomous. 
exposure to the factor of interest is ascertained, for each case and 
control. Lastly, an odds ratio for the outcome of interest (in relation to 
exposure status) is calculated. Case-control studies are retrospective 
because they seek to determine previous exposure after the outcome 
has been established. Thus, they are subject to recall or information 
bias. Case-control studies are also subject to sampling bias because it 
is difficult to select controls which are (ideally) perfectly similar to 
cases, with the exception of outcome status. However, techniques 
such as matching controls to cases and stratified analysis can improve 
the precision of estimates from case-control studies.  
Case-control studies are useful when attempting to isolate a cause 
or causes for an emerging disease condition. Most recently this 
approach was used in attempts to determine the factors contributing 
to Colony Collapse Disorder (CCD) (vanEngelsdorp et al., 2009b, 2010; 
Dainat et al., 2012)  
 
2.1.3.1. Data analysis and interpretation  
The data analysis is similar to that presented in cross-sectional study 
designs above. However, the results from case-control studies have 
more importance in determination etiology because exposure status is 
ascertained at a time prior to case and control status are determined. 
 
2.2. Experimental study designs 
In contrast to observational studies, an experimental study assigns 
subjects to different treatment or exposure levels. This type of study 
design can be used to investigate the change in health status due to 
disease screening programs, prevention plans, interventions, diagnostic 
techniques or treatment procedures. Ultimately, a research team 
decides who will be treated or exposed, which consequently results in 
experimental intervention, not just observation of natural events.   
Randomized studies are very powerful for investigating cause and 
effect because of the random assignment of study subjects to two or 
more intervention strategies, which leads to a compelling test of 
causality. The most simple randomized trial design consists of 
participants being randomly assigned to one of two treatment arms, 
the experimental arm (receive treatment of interest) or the control 
arm (receive no, placebo or standard treatment). Data from 
randomized trials can be utilized to calculate incidence of outcomes 
per treatment arm and then compare the incidence using the relative 
risk or risk differences.  Randomization helps protect against bias, 
because it is likely that potential confounders are equally distributed 
across the treatment and control study groups. The scope of 
randomized studies is limited because these studies aim to confirm or 
disprove a specific hypothesis. Additionally, the cost and time needed 
to conduct trials are two primary disadvantages of this study design. A 
third concern is that the results from a controlled randomized trial 
may not be generalizable to uncontrolled real-world settings. There 
are many different variations on the simple randomized study design 
in which randomization schemes are modified and researchers are 
blinded to study conditions.    
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3. Economic considerations 
 
Understanding those factors that are associated with a lower rate of 
loss may provide potential treatment options for beekeepers. 
However, just because a practice appears to be effective in reducing 
loss does not mean that it is necessarily in the beekeeper’s best 
interest to adopt it. An additional piece of information for apiary 
managers is how much the treatment will cost and how much money 
the producer will likely save with its application. 
Calculating the costs of practices in beekeeping is relatively 
straight forward, in that it includes the purchase cost of treatment and 
any labour or materials costs associated with its application.  While 
each producer can calculate their costs, accurate aggregate data are 
more difficult to obtain, particularly for labour costs, or for 
applications where producers use their own recipe. Thus, the true 
costs of treatment may vary from producer to producer, and individual 
managers can be guided to compare their own costs to the average 
for a better cost estimate. 
Calculating the benefit from reducing disease is more nuanced. 
One simple approach is to use the replacement cost of a hive as an 
estimate for the benefit of losing one less colony. To be as close as 
possible to the actual cost, one would like to find the replacement 
process that most closely replicates the scenario of having not lost the 
colony in the first place, such as a nuclear colony. Thus, one would 
not simply want to use the cost of splitting a hive, but would want a 
replacement that would be as productive as quickly as an existing 
colony while not reducing the productivity of surviving colonies. The 
true replacement costs would include extra feeding and labour costs 




Benefit of saving one colony = Replacement cost 
 
Where replacement cost = cost of nuclear colony + cost of feed + 
cost of labour 
Once one has a measure of the benefit of saving one colony, one 




Expected net benefit of treatment =  
Replacement cost x (mean survival of untreated colonies – mean 
survival of treated colonies) 
 
Where: mean survival = 100 - Average Loss 
If the cost of treatment exceeds the expected benefit, generating 
a negative expected net benefit, then despite the fact that the 
treatment may reduce colony loss, it may not be in the producer’s 
best interest to use that treatment. 
Note that the above calculation, even if all treatment and 
replacement costs are included, will tend to underestimate the 
benefits associated with treatment.  Disease not only affects mortality, 
it also affects productivity, which is not captured in the above 
calculation. Thus, the above calculation should be thought of as 
generating a lower bound on expected net benefit. A more nuanced 
approach would be to estimate the effect of treatment on disease 
load, and the effect of disease load on productivity of honey 
production, pollination or other revenue-generating activities. Further, 
some beekeepers may place personal value on not losing a colony, 
and for them, their expected benefit of treatment may be higher still. 
These data are more difficult to collect, and will likely vary greatly 
from producer to producer.  Nonetheless, giving beekeepers an 
estimate of the net benefit of treatment should allow them to 
compare the pure monetary costs and benefits to any other 




4. Inferring causal relationships 
using Hill’s Criteria 
To diagnose the cause of a disease in honey bees, scientists typically 
compare observed symptoms with a list of exposures in colonies that 
implicate a particular pathogen, toxin or other detrimental aspect of 
the environment. Confirming the cause of the particular instance of 
these symptoms is relatively straightforward – the scientist either 
tests for the presence of the diagnosed causal agent itself or removes 
it and checks for amelioration of the symptoms. These approaches are 
feasible when the symptoms occur at the level of the individual or 
colony, because effects on growth, short-term survival or reproduction 
are readily measured (see the BEEBOOK paper on measuring colony 
strength parameters (Delaplane et al., 2013)). In principle, it is 
possible to estimate the impact of the disease on the population’s 
dynamics by using demographic models that quantify the effect on 
population growth (Varley et al., 1973). 
There are some cases, however, that are problematic for two 
reasons. First, the symptom is itself a population-level attribute; for 
instance, a general population decline. Second, the normal procedure 
is reversed because the causal agent is already identified, albeit as a 
hypothesis. An example is the supposed role of trace dietary 
pesticides in causing honey bee declines. In this case, scientists are 
asked whether dietary exposure to the pesticide is capable of causing 
the observed population decline. Studying impacts at the population 
level by experiments with replicated comparisons presents a severe 
logistical challenge because the required manipulations are at the 
landscape scale. Some alternative tools are available, such as the 
classic ‘life table’ method of insect population ecology (Varley et al., 
1973), but these can be applied only if detailed census data are 
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available that precisely identify causes of death over extended time 
periods. Where such resorts are stymied, scientists must use the 
available circumstantial evidence to pass an expert judgement. Hill’s 
criteria (Hill, 1965) provide a valuable framework that supports a 
repeatable and quantitative evaluation process. 
Sir Austin Bradford Hill, a leading 20th century epidemiologist, 
identified nine types of information that provide ‘viewpoints’ from 
which to judge a proposed cause-effect relationship (Hill, 1965). The 
nine criteria include not only experimental evidence, but also eight 
kinds of circumstantial evidence that fall into two categories (Table 4). 
For each criterion, scientists survey the available evidence and 
then formally describe the level of conviction with which they 
subsequently hold the proposed cause-effect hypothesis to be true: 
slight; reasonable; substantial; clear; and certain (Weiss, 2006). The 
descriptors are then associated with numerical values to produce a 
quantitative score of certainty (Cresswell et al., 2012). Specifically, an 
eleven-point scale for each criterion returns a positive value 
(maximum five) if the evidence suggests that the agent certainly 
causes population decline, a negative value (maximum minus five) if 
the factor certainly does not and a zero if the evidence is equivocal or 
lacking.  For example, if the evidence for a criterion gives a 
reasonable indication that an agent does not cause the symptom, the 
score for that criterion would be -2, etc.   
Box 8. 
Using the numbers from the winter loss survey given in Box 6, we 
observed that beekeepers that used a known varroa mite control 
product lost 7.2% fewer colonies than beekeepers that did not use a 
product (29.5% versus 36.7% loss, respectively). To calculate the 
95% CI for the difference in the mean, we need to calculate 1.96 × 
s.e.d, where s.e.d is the standard error of the difference in means.   
The standard error of the difference, s.e.d is defined as 
 
   
where se1 is the standard error of the mean for sample 1, and 
s.e.2 is the standard error of the mean for sample 2. The standard 
error for the sample using treatment is 1.02 and the standard error 
for the control sample (or no-treatment sample) is 0.92. Thus, the 
standard error of the difference in means is 
 
 
If using the replacement costs of a hive, including labour and 
feeding are $150, then the expected benefit of the treatment is the 
change in probability of loss times the replacement costs, or 0.07 × 
$150 = $10.80 (95% CI  $8.07 to $13.53). Assume the cost of  
treatment is $7.50 per colony. Thus the expected net benefits would 
be $10.80 - $7.50 = $3.30 (95% CI $0.57 to $6.03) per hive. 
Thus, the producer is expected to benefit from the treatment and 
those benefits will range from $0.57 to $6.03, 95 times out of 100. 
 
One major value of the criteria is that they disaggregate the different 
kinds of evidence, requiring the scientist to consider each kind 
carefully, separately and explicitly. Once the scores are given, there is 
no a priori reason either to give equal weight to the nine criteria or to 
calculate an average score. It is important, moreover, to consider 
whether any large scores have arisen principally on the theoretical 
criteria, because it is conventional in science to favour material 
evidence (i.e. associational criteria) over conjecture. For example, an 
evaluation by Hill’s criteria (Cresswell et al., 2012) revealed that the 
proposition that dietary pesticides cause honey bee declines was a 
substantially justified conjecture in the context of current knowledge 
(positive scores on the theoretical criteria), but was substantially 
contraindicated by a wide variety of circumstantial evidence (negative 
scores on the associational criteria). The disparity in the scores on the 
two categories of criteria explains in part the controversy over this 
question, because different constituencies make differential use of the 
two kinds of evidence. Hill (1965) himself refused to weight the 
criteria because the evaluation of circumstantial evidence cannot be 
made algorithmic. 
The use of Hill’s criteria formalizes the evaluation of cause-
consequence associations and applies a quantitative scoring method 
which makes the conclusions both apparent and repeatable. Since 
their inception over 40 years ago and subsequent widespread use, no 
criterion has been abandoned and none added, which means that 
they provide a stable and well-established infrastructure in which to 




The general aim of all scientists studying honey bee health is the 
same; preservation of the bees.  However, without common methods 
and shared terminology, it is difficult to confidently compare reported 
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Table 4. The nine criteria established by Hill (1965), each with a brief 
description. 
Criterion Brief description 
1. Experimental evidence   
2. Coherence Fails to contradict established knowledge 
3. Plausibility Probable given established knowledge 
4. Analogy Similar examples known 
5. Temporality Cause precedes effect 
6. Consistency Cause is widely associated with effect 
7. Specificity Cause is uniquely associated with effect 
8. Biological gradient Monotonic dose-response relationship 
9. Strength 
Cause is associated with a substantive 
effect 
results. In an effort to standardize the efforts of those interested in 
improving honey bee health and make studies comparable, we have 
introduced epidemiological terminology, experimental design, and 
methods of calculation that are often different enough to preclude 
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